S3841 Gene test retinoblastoma
Also known as: RB1 gene test, retinoblastoma genetic testing
Genetic testing for mutations in the RB1 tumor suppressor gene associated with retinoblastoma and increased cancer predisposition.
In Plain Language
genetic test for eye cancer; retinoblastoma cancer gene test
Clinical Context
Used in ophthalmology and medical oncology for screening of retinoblastoma patients and families with hereditary cancer predisposition.
RVU Information
CPT S3841 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
S-codes are used by private payers (not Medicare) for services without a standard CPT or HCPCS code. Coverage varies significantly between insurers. Verify payer acceptance before billing and document medical necessity thoroughly.
Specialties
Frequently Asked Questions
What is CPT code S3841?
CPT S3841 (Gene test retinoblastoma) is a S Codes code. Genetic testing for mutations in the RB1 tumor suppressor gene associated with retinoblastoma and increased cancer predisposition.
Is S3841 covered by insurance?
S3841 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used in ophthalmology and medical oncology for screening of retinoblastoma patients and families with hereditary cancer predisposition.
When is CPT S3841 used?
Used in ophthalmology and medical oncology for screening of retinoblastoma patients and families with hereditary cancer predisposition.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.